Compound Detail
CHEMBL54349
ALPIDEM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL54349 |
| Name | ALPIDEM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | JRTIDHTUMYMPRU-UHFFFAOYSA-N |
7
Targets
24
Activities
3
Assay Types
1
PK Parameters
20
Publications
3
Known Names
1
Mechanisms
Molecular Properties
404.3
MW (Da)
5.50
ALogP
3
HBA
0
HBD
37.6
PSA (Ų)
0.52
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Withdrawn |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Translocator protein partial agonist | PARTIAL AGONIST | Translocator protein | ✓ | ✓ |
Drug Warnings
Withdrawn
hepatotoxicity
Hepatitis
Withdrawn
hepatotoxicity
Hepatitis
Withdrawn
hepatotoxicity
Hepatitis
Activity Summary
IC50 13 meas. best 9.3
Ki 10 meas. best 9.3
Kd 1 meas. best 5.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Translocator protein CHEMBL4552 | IC50 | 9.3 | 8.5167 | 0.5 | 3 |
| Translocator protein CHEMBL4552 | Ki | 9.3 | 8.83 | 0.5 | 5 |
| Translocator protein CHEMBL5742 | Ki | 9.3 | 9.3 | 0.5 | 3 |
| Unchecked CHEMBL612545 | IC50 | 9.0 | 8.29 | 1.0 | 2 |
| Unchecked CHEMBL612545 | Ki | 9.0 | 9.0 | 1.0 | 2 |
| Translocator protein CHEMBL5742 | IC50 | 8.1 | 8.1 | 7.9 | 1 |
| GABA-A receptor; anion channel CHEMBL1907607 | IC50 | 7.58 | 7.565 | 26.0 | 2 |
| Albumin CHEMBL3253 | Kd | 5.7 | 5.7 | 2000.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 5.04 | 5.04 | 9155.0 | 4 |
| Bile salt export pump CHEMBL2073674 | IC50 | 4.64 | 4.64 | 23000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 285.0 | nM | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | 2 |
Data from ChEMBL 36 via Core Engine